View in EDS HTML Full Text PDF Full Text

Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial.
Authors: Gabriel, Rafael1,2,3 (AUTHOR) rgabriel@ceiis.org, Boukichou-Abdelkader, Nisa3,4 (AUTHOR), Gilis-Januszewska, Aleksandra5 (AUTHOR), Makrilakis, Konstantinos6 (AUTHOR), Gómez-Huelgas, Ricardo7 (AUTHOR), Kamenov, Zdravko8 (AUTHOR), Paulweber, Bernhard9 (AUTHOR), Satman, Ilhan10 (AUTHOR), Djordjevic, Predrag11 (AUTHOR), Alkandari, Abdullah12 (AUTHOR), Mitrakou, Asimina13 (AUTHOR), Lalic, Nebojsa14 (AUTHOR), Egido, Jesús15 (AUTHOR), Más-Fontao, Sebastián15 (AUTHOR), Calvet, Jean Henri16 (AUTHOR), Pastor, José Carlos17 (AUTHOR), Lindström, Jaana18 (AUTHOR), Lind, Marcus19,20,21 (AUTHOR), Acosta, Tania22 (AUTHOR), Silva, Luis4 (AUTHOR)
Source: Journal of Clinical Medicine. Mar2023, Vol. 12 Issue 5, p2035. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm12052035